Ann Ginsberg is Chief Medical Officer and a member of the Executive Office at Aeras, a not-for-profit organization developing improved tuberculosis (TB) vaccines for the world. At Aeras, Dr. Ginsberg oversees all clinical activities and shares executive responsibility for the organization with the CEO and Chief Scientific Officer. She has been at Aeras since 2011. From 2004 to 2011, Dr. Ginsberg was Head of Clinical Development and then Chief Medical Officer at the Global Alliance for TB Drug Development. From 2002 to 2004, she was Director, Project Management at Merck Research Laboratories. Dr. Ginsberg began her career in TB at the U.S. NIH, where she served in a number of positions, culminating in Chief, Respiratory Diseases Branch, National Institute of Allergy and Infectious Diseases (NIAID).
Dr. Ginsberg is a member of the U.S. Government’s National Vaccine Advisory Committee and has served on numerous global health advisory committees over the years. Dr. Ginsberg is Board Certified in Anatomic Pathology and holds an AB from Harvard University, an MD from Columbia University, and a PhD in molecular biology from Washington University.